{"date":"2025-12-11","count":20,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7427-2025-12-11-1856-84656m","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-11","time":"18:56:06","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"第11款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-12-11 18:56，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-12-11-1855-1oqziqy","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-11","time":"18:55:06","subject":"公告本公司經理人晉升案","clause":"第11款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-12-11 18:55，「公告本公司經理人晉升案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-12-11-1854-1866mw7","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-12-11","time":"18:54:27","subject":"公告本公司董事會決議增資持股100%之美國子公司Tanvex BioPharma USA, Inc.","clause":"第20款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-12-11 18:54，「公告本公司董事會決議增資持股100%之美國子公司Tanvex BioPharma USA, Inc.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-12-11-1854-1uhskx3","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-11","time":"18:54:20","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-12-11 18:54，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-12-11-1840-145607p","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-12-11","time":"18:40:18","subject":"代重要子公司Tanvex BioPharma USA, Inc.公告董事會決定辦理現金增資","clause":"第11款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-12-11 18:40，「代重要子公司Tanvex BioPharma USA, Inc.公告董事會決定辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-12-11-1811-7ucnq5","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"18:11:22","subject":"代子公司HUA KUANG MEDICAL HOLDING LIMITED(華光)公告本公司董事會授權董事長簽訂股權轉讓意向書","clause":"第10款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-12-11 18:11，「代子公司HUA KUANG MEDICAL HOLDING LIMITED(華光)公告本公司董事會授權董事長簽訂股權轉讓」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-12-11-1713-b0way5","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"17:13:07","subject":"本公司公告資金貸與美金貳仟參佰萬元予TCI Biotech USA LLC一案","clause":"第23款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-12-11 17:13，「本公司公告資金貸與美金貳仟參佰萬元予TCI Biotech USA LLC一案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-12-11-1712-1ufvfad","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"17:12:36","subject":"代子公司TCI BIOTECH USA LLC公告購置美國不動產","clause":"第20款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-12-11 17:12，「代子公司TCI BIOTECH USA LLC公告購置美國不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-12-11-1705-l4k39t","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"17:05:55","subject":"公告接獲合作夥伴健康元藥業集團通知抗流感病毒新藥Pixavir marboxil通過中國大陸國家藥品監督管理局（NMPA）新藥審查，取得新藥上市許可。","clause":"第10款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-12-11 17:05，「公告接獲合作夥伴健康元藥業集團通知抗流感病毒新藥Pixavir marboxil通過中國大陸國家藥品監督管理局（NMPA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-12-11-1629-1v20vp9","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-12-11","time":"16:29:45","subject":"公告本公司董事會決議辦理現金增資發行新股案","clause":"第9款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-12-11 16:29，「公告本公司董事會決議辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-12-11-1612-1uhskx3","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-12-11","time":"16:12:35","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-12-11 16:12，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-12-11-1607-1aq7iqo","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"16:07:53","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-12-11 16:07，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-12-11-1546-18bh50w","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"15:46:01","subject":"公告本公司114年11月份自結合併損益","clause":"第53款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-12-11 15:46，「公告本公司114年11月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-12-11-1510-aiikgl","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"15:10:21","subject":"本公司受邀參加凱基證券舉辦之法說會","clause":"第12款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-12-11 15:10，「本公司受邀參加凱基證券舉辦之法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-12-11-1455-69e4qk","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-12-11","time":"14:55:23","subject":"本公司受邀參加富邦綜合證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-12-11 14:55，「本公司受邀參加富邦綜合證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-12-11-1439-9xuotf","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"14:39:59","subject":"代子公司太景醫藥研發(北京)有限公司公告董事會通過財務主管任命案。","clause":"第8款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-12-11 14:39，「代子公司太景醫藥研發(北京)有限公司公告董事會通過財務主管任命案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-12-11-1416-2194gb","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-12-11","time":"14:16:48","subject":"本公司受邀參加中國信託於114年12月17日舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-12-11 14:16，「本公司受邀參加中國信託於114年12月17日舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-12-11-1056-18aq2yk","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-12-11","time":"10:56:53","subject":"說明媒體報導","clause":"第51款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-12-11 10:56，「說明媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-12-11-0852-1xzke75","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-12-11","time":"08:52:01","subject":"本公司與越南英發集團旗下英發農業科技股份公司簽署合作備忘錄","clause":"第8款","fact_date":"2025-12-11","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-12-11 08:52，「本公司與越南英發集團旗下英發農業科技股份公司簽署合作備忘錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-12-11-0630-1mt2480","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-12-11","time":"06:30:09","subject":"本公司與跨國大藥廠BeOne Medicines已正式簽署一項國際臨床合作協議，將評估CX-5461與該公司已上市PD-1抑制劑tislelizumab併用於多項晚期腫瘤臨床試驗。","clause":"第10款","fact_date":"2025-12-10","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-12-11 06:30，「本公司與跨國大藥廠BeOne Medicines已正式簽署一項國際臨床合作協議，將評估CX-5461與該公司已上市PD-」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}